Cargando…
Case of HER2neu+ Invasive Pleomorphic Lobular Carcinoma With Response to Conventional Neoadjuvant Chemotherapy: A Viable Option for an Exceedingly Rare Breast Cancer Type
Invasive pleomorphic lobular carcinoma (IPLC) is an extremely rare form of breast cancer that accounts for less than 1% of all breast cancer cases. Due to this rarity, currently, there is a lack of an established standard of care for patients diagnosed with this form of breast cancer. In this case r...
Autores principales: | Nelson, Blessie, Brizendine, Ashley M, Gietzen, Rachelle, Venkatesan, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682532/ https://www.ncbi.nlm.nih.gov/pubmed/33240704 http://dx.doi.org/10.7759/cureus.11108 |
Ejemplares similares
-
CD5+ Diffuse Large B-Cell Lymphoma With Leukemic Transformation: A Rare Case With Central Nervous System Involvement, Treated With R-CHOP and Intrathecal Methotrexate/Cytarabine
por: Cordova, Justin, et al.
Publicado: (2021) -
Pleomorphic Invasive Lobular Carcinoma of the Breast With
Extracellular Mucin and HER2 Amplification
por: Burky, Matthew J, et al.
Publicado: (2020) -
Single-Institute Review of HER-2/Neu-Positive Invasive Lobular Breast Carcinoma in an Arab Population
por: Osmani, Asif Husain, et al.
Publicado: (2021) -
Targetable alterations in invasive pleomorphic lobular carcinoma of the breast
por: Riedlinger, Gregory M., et al.
Publicado: (2021) -
Clinicopathological and Molecular Characteristics of Pleomorphic Invasive Lobular Carcinoma
por: Segar, Jennifer M., et al.
Publicado: (2020)